Product NDC: | 0703-3154 |
Proprietary Name: | Bleomycin |
Non Proprietary Name: | Bleomycin |
Active Ingredient(s): | 15 [USP'U]/1 & nbsp; Bleomycin |
Administration Route(s): | INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-3154 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065033 |
Marketing Category: | ANDA |
Start Marketing Date: | 20000630 |
Package NDC: | 0703-3154-01 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0703-3154-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
NDC Code | 0703-3154-01 |
Proprietary Name | Bleomycin |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0703-3154-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
Product NDC | 0703-3154 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Bleomycin |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20000630 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | BLEOMYCIN SULFATE |
Strength Number | 15 |
Strength Unit | [USP'U]/1 |
Pharmaceutical Classes | Cytoprotective Agent [EPC] |